Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. mechanical ventilation
Show results for
Products
Services
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Mechanical Ventilation Articles & Analysis

37 news found

Validating The BLEO-Induced Mouse Model For Drug Discovery

Validating The BLEO-Induced Mouse Model For Drug Discovery

Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive scarring of the lungs, which severely impairs lung function over time. Developing effective treatments for IPF has been a challenge for the medical community, as the mechanisms driving this disease are complex and not fully understood. To accelerate drug discovery, animal models that closely mimic the ...

BySCIREQ - an emka TECHNOLOGIES Company


World TB Day and Infection Control Resources in New York City to Help Prevent New Cases

World TB Day and Infection Control Resources in New York City to Help Prevent New Cases

In addition to air testing utilizing highly sensitive real-time Polymerase Chain Reaction (PCR) techniques to help to stop the spread of Mycobacterium tuberculosis, CTSI also helps to mitigate exposure risks through their expertise in mechanical ventilation, engineering controls, and other methods to protect patients, workers, and building occupants in healthcare ...

ByCochrane & Associates, LLC


Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022

Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022

” Results from the analytical and clinical studies conclude that the Symphony IL-6 Test is an innovative technology for use in Emergency Department and Intensive Care Unit settings to identify COVID-19 patients at higher risk for severe disease, including the requirement for Invasive Mechanical Ventilation (IMV). This conclusion is based on the study ...

ByBluejay Diagnostics, Inc.


N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube

N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube

N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield™ endotracheal tube (CeraShield™ ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours. N8 Medical is encouraged by preliminary study data and believes that the CeraShield™ ETT will ...

ByN8 Medical, LLC


World TB Day and Preventing New Cases in Healthcare Facilities and Correctional Institutions in Puerto Rico

World TB Day and Preventing New Cases in Healthcare Facilities and Correctional Institutions in Puerto Rico

Zimmetry’s building science professionals can help to mitigate exposure concerns with their expertise in mechanical ventilation, engineering controls and other methods to protect building occupants in Puerto Rico and throughout the Caribbean. ...

ByCochrane & Associates, LLC


It All Starts With Patient Safety at Medovate

It All Starts With Patient Safety at Medovate

HUMIDICARE® is a novel Heat and Moisture Exchanger (HME) which visually alerts clinical staff to a dual humidification error in mechanical ventilation circuits. Artificial humidification systems are used with ventilated patients in the operating theatre or intensive care unit. ...

ByMedovate


Lungpacer Medical Accelerates Pivotal Clinical Study with AeroPace™ System

Lungpacer Medical Accelerates Pivotal Clinical Study with AeroPace™ System

Lungpacer Medical, a leading medical device innovation company, today announced the introduction of the AeroPace™ System, a next generation product, into the RESCUE 3 pivotal clinical study studying faster ventilator independence. Lungpacer is dedicated to natural breathing by developing minimally invasive technologies designed to help patients wean off ...

ByLungpacer Medical Inc.


CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)

CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)

Chan continued, “ECMO is a machine that pumps and oxygenates blood outside the body when a patient’s lungs are so diseased that mechanical ventilation fails. Without ECMO, these patients – often considered among the sickest in the ICU – would normally die. ...

ByCytoSorbents Corporation


FDA Grants the Hemolung® De Novo Clearance

FDA Grants the Hemolung® De Novo Clearance

“The Hemolung will be an important new treatment modality for acute respiratory failure to avoid or mitigate the harms from invasive mechanical ventilation. FDA clearance of the Hemolung is a game-changer for the treatment of these critically ill patients and will usher in a new era of extracorporeal lung support,” said Steven Conrad, MD, PhD, MCCM, ...

ByLivaNova PLC


Avery Biomedical Devices’ Nextgen Diaphragm Pacing Transmitter, Spirit, Earns FDA Approval – Now Available

Avery Biomedical Devices’ Nextgen Diaphragm Pacing Transmitter, Spirit, Earns FDA Approval – Now Available

For patients who do meet the criteria, diaphragm pacemakers have been found to be a better alternative to mechanical ventilators. They offer greater mobility and independence; the ability to more easily perform daily activities like getting dressed, bathing and transferring from a wheelchair; lower risk of infections, pneumonia, collapsed lungs, airway injuries ...

ByAvery Biomedical Devices, Inc.


National Patient Safety Agency Alert Concerning Nebulisers

National Patient Safety Agency Alert Concerning Nebulisers

Sitting easily in line and without the need to break the circuit7, Aerogen is suitable for multiple areas across the hospital including those providing mechanical ventilation, non-invasive ventilation, high flow nasal cannula oxygen therapy as well as use in spontaneously breathing patients on wards, emergency departments and outpatients2. ...

ByAerogen


Data from Eli Lilly’s COV-BARRIER trial shows baricitinib reduced deaths in hospitalised COVID-19 patients by 38%

Data from Eli Lilly’s COV-BARRIER trial shows baricitinib reduced deaths in hospitalised COVID-19 patients by 38%

The trial did not meet statistical significance on the primary endpoint, defined as a difference in the proportion of participants progressing to the first occurrence of non-invasive ventilation including high flow oxygen or invasive mechanical ventilation including extracorporeal membrane oxygenation (ECMO) or death by Day 28. ...

ByBenevolent


IONICON Analyzers at the Forefront of International COVID-19 Testing Research

IONICON Analyzers at the Forefront of International COVID-19 Testing Research

Grassin-Delyle et al. focused on adults undergoing invasive mechanical ventilation in the intensive care unit due to severe COVID-19 or non-COVID-19 acute respiratory distress syndrome (ARDS). ...

ByIonicon Analytik Ges.m.b.H.


ACTT-2 trial results published in the New England Journal of Medicine validate baricitinib’s efficacy in combination with remdesivir in hospitalised COVID-19 patients

ACTT-2 trial results published in the New England Journal of Medicine validate baricitinib’s efficacy in combination with remdesivir in hospitalised COVID-19 patients

But for people who were on the edge of requiring invasive ventilation, median recovery time fell from 18 days on remdesivir alone to 10 days on both drugs. ...

ByBenevolent


Liberate Medical Reports Positive Pilot Trial Results of VentFree Respiratory Muscle Stimulator

Liberate Medical Reports Positive Pilot Trial Results of VentFree Respiratory Muscle Stimulator

Applying non-invasive electrical stimulation to the expiratory abdominal muscles may reduce abdominal muscle atrophy and markedly reduce the number of days adult patients require mechanical ventilation – a potentially important finding for weaning ventilated patients, including seriously ill COVID-19 patients, and improving patient ...

ByLiberate Medical, LLC


Dexamethasone reportedly part of President Trump’s Treatment

Dexamethasone reportedly part of President Trump’s Treatment

The National Institutes of Health (NIH) recently updated its COVID-19 treatment guidelines to include treatment of up to 6 mg per day of dexamethasone for up to 10 days in patients that require supplemental oxygen, or those who are are mechanically ventilated. Prior to that, the NIH amended the treatment guidelines to recommend low-dose corticosteroid therapy ...

ByAVM Biotechnology


N8 Medical Announces its CeraShield™ Coating inhibits COVID-19 Virus Growth on Endotracheal Tubes

N8 Medical Announces its CeraShield™ Coating inhibits COVID-19 Virus Growth on Endotracheal Tubes

COVID-19 patients who become mechanically ventilated will require use of one of these plastic tubes to connect to the mechanical ...

ByN8 Medical, LLC


First COVID-19 Patient in Germany successfully treated with novel Diaphragm Therapy

First COVID-19 Patient in Germany successfully treated with novel Diaphragm Therapy

“The first patient treated in this trial happened to be a woman who survived COVID-19 but was not able to be weaned from mechanical ventilation,” said Prof. Dr. Ralf Ewert, the head of the Pneumology, Infection Disease and Weaning Centre at the University Medical School of Greifswald. “With the new procedure, we were able to treat this patient, ...

ByLungpacer Medical Inc.


Sommetrics and aerFree, LLC Contributing to Treatment of COVID-19

Sommetrics and aerFree, LLC Contributing to Treatment of COVID-19

” Sommetrics also filed an Emergency Use Authorization request to use a modified aerSleep® product to support patients with COVID-19 related respiratory impairment who are not candidates for mechanical ventilation. aerSleep®, which is intended to treat obstructive sleep apnea using an integrated vacuum source, has been modified to utilize readily ...

BySommetrics


VentFree Respiratory Muscle Stimulator receives FDA Emergency Use Authorization for Use During COVID-19 Pandemic

VentFree Respiratory Muscle Stimulator receives FDA Emergency Use Authorization for Use During COVID-19 Pandemic

Liberate Medical today announced that it has received Federal Drug Administration (FDA) Emergency Use Authorization for its VentFree™ Respiratory Muscle Stimulator, intended to be used to reduce disuse atrophy of the abdominal wall muscles, which may reduce the number of days adult patients require mechanical ventilation, including those patients with ...

ByLiberate Medical, LLC

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT